NLRP3 and Parkinson disease: The present study found that IL-10 suppressed NOX2-derived iROS to block NLRP3 inflammasome activation and cleavage of caspase-1 and pro-IL-1β, thereby preventing IL-1β secretion and chronic neuroinflammation in in vitro and in vivo models of PD.